Cryopreservation of adherent human embryonic stem cells

Biotechnol Bioeng. 2004 Nov 5;88(3):299-312. doi: 10.1002/bit.20243.

Abstract

Standard human embryonic stem (HES) cell cryopreservation methodologies, including slow freezing and vitrification of colonies in suspension, are plagued by poor viability and high differentiation rates upon recovery. To facilitate research studies and clinical applications of HES cells, we have developed a cryopreservation technique based on stabilizing HES colonies adherent to or embedded in a Matrigel matrix. This method increases cell viability by over an order of magnitude compared with cryopreservation in suspension and reduces differentiation. Loading adherent HES cells with the disaccharide trehalose prior to cryopreserving in a dimethylsulfoxide-containing cryoprotectant solution further improves cell viability under certain conditions. Our proposed approach has the potential to reduce the time required to amplify frozen stocks of HES cells, minimize risk of clonal selection during freeze-thaw cycles, and facilitate storage of HES cell clone libraries.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials / chemistry
  • Cell Adhesion / physiology*
  • Cell Culture Techniques / methods*
  • Cell Line
  • Cell Survival / physiology
  • Collagen / chemistry*
  • Cryopreservation / methods*
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Humans
  • Laminin / chemistry*
  • Proteoglycans / chemistry*
  • Stem Cells / chemistry
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • Stem Cells / physiology*
  • Tissue Engineering / methods*
  • Trehalose / chemistry
  • Trehalose / pharmacology*

Substances

  • Biocompatible Materials
  • Drug Combinations
  • Laminin
  • Proteoglycans
  • matrigel
  • Collagen
  • Trehalose